Matrixx Initiatives Competitors and Similar CompaniesClear all
UCB's competitors and similar companies include Livzon Pharmaceutical Group and Biogen.
 UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 1928 | Founding Date 1985 | Founding Date 1978 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 9,052 | Employees 9,067 | Employees 7,605 |
Valuation ($) | Valuation ($) 34.3 b | Valuation ($) 4.2 b | Valuation ($) 26.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods €1.4b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit €7.2b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit $7.5b (FY, 2025) |
Net income | Net income €1.6b (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company